ScholarLens Back to search
2018•Journal of the Pediatric Infectious Diseases SocietyRequires access

Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation

Fouad Madhi, Corinne Lévy, Laurence Morin, Philippe Minodier, François Dubos, Férielle Zenkhri, Marie Aliette Dommergues, Ellia Mezgueldi, Karine Levieux, Pneumonia Study Group, Marie Aurel, Elise Launay, Sandra Biscardi, Laure Hees, Irina Craiu, Yves Gillet, Christèle Gras‐Le Guen, Isabelle Hau, Mathie Lorrot, Alain Martinot, François Angoulvant, Stéphane Béchet, Emmanuelle Varon, Robert W. Cohen, GPIP (Pediatric Infectious Disease Group), Fouad Madhi, Corinne Lévy, Laurence Morin, Philippe Minodier, François Dubos, Férielle Zenkhri, Marie Aliette Dommergues, Ellia Mezgueldi, Karine Levieux, Emmanuelle Varon, Robert W. Cohen

Open publisher page 53 citations

Abstract

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).

About this research paper

What this paper is about

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).

Key concepts: Medicine, Empyema, Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Parapneumonic effusion, Conjugate vaccine, Pleural effusion, Bacterial pneumonia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation — Research Paper | ScholarLens